Jing Pan

8PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 01, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial.

Jing Pan, Yue Tan, Lingling Shan

|Jul 29, 2021
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial.

Jing Pan, Yue Tan, Guoling Wang

|Dec 14, 2020
Ruxolitinib mitigates steroid-refractory CRS during CAR T therapy.

Jing Pan, Biping Deng, Zhuojun Ling

Pageof 2